BioCentury
ARTICLE | Financial News

Atugen raises EUR 20 million

July 31, 2000 7:00 AM UTC

The gene target identification and validation company Atugen (Berlin, Germany) raised EUR 20 million ($18.7 million) through a private second round financing. Investors included Apax Partners; BB BioV...